Skip to main content

What the FDA labels say about taking them together

Teriflunomide and tizanidine

Teriflunomide's FDA label of February 20, 2026 names tizanidine in its drug interactions section; the tizanidine labels PlainMeds reads (3) do not name teriflunomide. The teriflunomide label: “In patients taking AUBAGIO, exposure of drugs metabolized by CYP1A2 may be reduced.”

Check it at the source: the teriflunomide FDA label on DailyMed (effective February 20, 2026, Genzyme Corporation); the tizanidine FDA label on DailyMed (effective January 2, 2026, Legacy Pharma USA, Inc.).

What does the teriflunomide label say about tizanidine?

Teriflunomide label, drug interactions

In patients taking AUBAGIO, exposure of drugs metabolized by CYP1A2 (e.g., alosetron, duloxetine, theophylline, tizanidine) may be reduced.

Source: FDA drug label (Aubagio), NDA202992 (Sanofi Aventis Us), as published by Genzyme Corporation, effective February 20, 2026 (SPL set 4650d12c-b9c8-4525-b07f-a2d773eca155), via openFDA; the full label on DailyMed

What does the tizanidine label say about teriflunomide?

Tizanidine's label (effective January 2, 2026) and its 2 other brand-application labels do not name teriflunomide in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Zanaflex), Legacy Pharma USA, Inc., effective January 2, 2026 (SPL set 60c27d35-7349-4fc6-86ad-70fffdbe3e08), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

15Teriflunomide generic labelers
49Tizanidine generic labelers
TeriflunomideTizanidine
Labeled forMultiple sclerosisMuscle spasms and spasticity
Boxed warningYesNo
Pharmacy cost (NADAC)$0.233 per tablet 14 mg tablet$0.0331 per tablet 4 mg tablet
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?